Overview
Cervical cancer is a malignancy of the cells of the cervix, the lower, narrow portion of the uterus that opens into the vagina, and is caused predominantly by persistent infection with high-risk types of the human papillomavirus (HPV). It ranks among the most common cancers affecting women worldwide and frequently produces no symptoms in its early stages, so it can cause serious harm if not detected and treated early. Because the disease typically arises through identifiable precancerous changes of the cervical epithelium, it is largely preventable through HPV vaccination and regular screening, with treatment of established cancer involving surgery, radiotherapy including brachytherapy, and chemotherapy. In a context concerned with women's reproductive and gynecological health and biomarkers, research in this field centers on screening, detection, and tumor biology. Published studies examine the uptake and determinants of cervical cancer screening across varied populations, including hospital staff, rural communities, and refugee women, and assess the prevalence of abnormal cervical cytology. Other work investigates molecular and cellular features of the disease, including the role of HPV in virus-induced carcinogenesis, signaling pathways such as PI3K/mTOR/AKT in cervical tumors, and immunohistochemical markers in intraepithelial and benign cervical lesions, alongside comparative treatment outcomes and broader studies of tumor cell biology and approaches to cancer prevention, reflecting the journal's interest in markers relevant to detection and prognosis.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Awareness of Cervical Cancer Screening test Among Women of Child Bearing age in the Rural Area of Awo-Omamma, Imo State, Nigeria.
Uptake of Cervical Cancer Screening Among Female Staff at the University College Hospital, Ibadan
Cervical Cancer with The Active And Stable PI3K/MTOR/AKT Pathway In Azerbaijan Patients
Comparative Survival Assessment of Two-Dimension (2D) vs Three-Dimension (3D) Brachytherapy Treatment in Cervical Cancer: A Retrospective Case Control Study
Gene-Eden-VIR: A Potential Natural Treatment for Cervical Cancer
P16/INK4a and KI-67 Evaluation of Intraepithelial and Benign Cervical Lesions at the University College Hospital, Ibadan - A Retrospective Immunohistochemically Study
The Prevalence of Abnormal Cervical Pap Smears in Women with Morbid Obesity in Dubai, United Arab Emirates
Review: The Role of Human Papillomavirus in Virus-Induced Carcinogenesis
Overexpression of Prostate Apoptosis Response Protein-4 In Colon Cancer Cells Can Inhibit Metastasis by Upregulating E-cadherin Expression
Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1)
How this research is being cited
The 12 articles above have been cited 13 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2023 · Ibnosina Journal of Medicine and Biomedical Sciences
-
Jaekwon Seok et al. · 2023 · Journal of Translational Medicine
-
2023 · Ibnosina Journal of Medicine and Biomedical Sciences
-
Saptadwipa Ganguly et al. · 2022 · Tumor Suppressor Par-4
-
Iman Ehsan et al. · 2022 · Journal of Drug Delivery Science and Technology
-
2022 · Springer eBooks
-
R. Irby et al. · 2021 · Tumor Suppressor Par-4
-
2021 · Journal of the Scientific Society
A sample of recent works citing this journal's research on Cervical Cancer, linking to each citing work.